Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.
Recalled by Nexgen Pharma, INC. on Apr 15, 2013
Reason for Recall
Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
Product Description
Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.
Distribution
Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).
What Should You Do?
- 1.Check your kitchen for this product immediately.
- 2.Do not consume the recalled product.
- 3.Return the product to where you bought it for a full refund, or throw it away.
- 4.If you have experienced any health issues, contact your healthcare provider.
Browse Related Recalls
Terms Explained
- Class III Recall — learn what this means in food safety
- FDA Food Recall — learn what this means in food safety
The this entity record above pulls directly from the FDA openFDA enforcement-report API. What follows is the per-entity context — how this entity sits in the broader U.S. FDA food, drug, and device recalls distribution and which underlying factors drive the headline numbers.
Every number on this page links back to the FDA openFDA enforcement-report API; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. consumer-product recalls. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.
Source: FDA Recalls, Market Withdrawals and Safety Alerts, 2026.